U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07694700) titled 'Colistin and Meropenem Versus Amikacin and Meropenem for MDR Gram Negative Bacteria Regarding Efficacy and Safety.' on June 28.
Brief Summary: Objective of this study is to compare the efficacy and safety between combination of colistin and meropenem and combination of amikacin and meropenem for multi-drug-resistant gram-negative bacteria in Intensive Care Unit. In Beni- Suef University Hospital.
Study Start Date: Dec. 30, 2025
Study Type: INTERVENTIONAL
Condition:
MDR Bacteria
Intervention:
DRUG: Colistimethate sodium for injection, meropenem
compare the efficacy and safety between combination of colistin and meropenem and c...